Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY). In a filing disclosed on February 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in DENTSPLY SIRONA stock on January 7th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of ICF International (NASDAQ:ICFI) on 2/3/2025.
• Purchased $15,001 – $50,000 in shares of CACI International (NYSE:CACI) on 1/31/2025.
• Purchased $50,001 – $100,000 in shares of Hawaiian Electric Industries (NYSE:HE) on 1/31/2025.
• Sold $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Intuitive Surgical (NASDAQ:ISRG) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Agios Pharmaceuticals (NASDAQ:AGIO) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of Paragon 28 (NYSE:FNA) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of U.S. Physical Therapy (NYSE:USPH) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 1/29/2025.

DENTSPLY SIRONA Stock Up 1.8 %

Shares of XRAY traded up $0.34 during midday trading on Thursday, hitting $18.71. The company had a trading volume of 1,058,291 shares, compared to its average volume of 2,297,587. The company’s 50-day simple moving average is $19.04 and its 200-day simple moving average is $22.04. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $34.91. The firm has a market capitalization of $3.72 billion, a P/E ratio of -9.03, a P/E/G ratio of 1.83 and a beta of 0.96.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were issued a dividend of $0.16 per share. The ex-dividend date was Friday, December 27th. This represents a $0.64 annualized dividend and a yield of 3.42%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -30.92%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Creative Planning grew its holdings in DENTSPLY SIRONA by 53.9% during the second quarter. Creative Planning now owns 16,540 shares of the medical instruments supplier’s stock worth $412,000 after acquiring an additional 5,793 shares during the period. Sanctuary Advisors LLC purchased a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at about $481,000. GAMMA Investing LLC boosted its holdings in DENTSPLY SIRONA by 133.4% during the third quarter. GAMMA Investing LLC now owns 2,488 shares of the medical instruments supplier’s stock worth $67,000 after buying an additional 1,422 shares in the last quarter. CWM LLC boosted its holdings in DENTSPLY SIRONA by 118.2% during the third quarter. CWM LLC now owns 7,337 shares of the medical instruments supplier’s stock worth $199,000 after buying an additional 3,975 shares in the last quarter. Finally, UMB Bank n.a. grew its position in DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 753 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on XRAY. Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. Mizuho started coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price on the stock. Evercore ISI reaffirmed an “in-line” rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Finally, UBS Group reduced their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Nine analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA has an average rating of “Hold” and an average target price of $26.33.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.